Brief: Initiator Pharma Says Mac Clinical Research Converts Receivable Into Shares
Feb 21 (Reuters) - Initiator Pharma A/S INIT.ST :
* MAC CLINICAL RESEARCH CONVERTS ITS RECEIVABLE INTO SHARES
IN
INITIATOR PHARMA
* CONVERSION OF GBP 2,000,000 IN CONNECTION WITH COMPANY'S
RECEIPT
OF A CONVERSION NOTICE FROM MAC
Source text for Eikon: ID:nMFN64x5T1
Further company coverage: INIT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Initiator Pharma A/S
See all newsBrief: Initiator Pharma Q1 2026 Operating Loss DKK 11.4 Mln
Brief: Initiator Pharma To Fully Prioritize Pudafensine
Brief: Initiator Pharma Reports Q4 Net Revenue Of DKK 0.00
Brief: Initiator Pharma Q4 Operating Loss Widens To DKK 7 Mln
Brief: Initiator Pharma Granted European Patent For Pudafensine in FSD